Cardiff Oncology, Inc.
Biotechnology company · San Diego, California, United States · Nasdaq: CRDF
Cardiff Oncology, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker CRDF. It has reported private securities offerings to the US SEC, most recently $14 million sold in a notice filed in 2020.
Cardiff Oncology at a glance
What does Cardiff Oncology do?
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $13.5 million sold (2020).
Frequently asked questions about Cardiff Oncology
Where is Cardiff Oncology headquartered?
Cardiff Oncology, Inc. is headquartered in San Diego, California, United States.
What does Cardiff Oncology do?
Cardiff Oncology, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Cardiff Oncology a public company?
Yes. Cardiff Oncology, Inc. trades on Nasdaq under the ticker CRDF.
Similar companies
- Biolinq IncSan Diego, California, United States
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.